Skip to content
Next in Austin
Latest
PeopleBryan Chambers Takes the Helm at Capital Factory After Cofounder's Death/PeopleJoshua Baer, Architect of Austin's Startup Boom, Dies at 50/NationalSpaceX goes public in record $75B IPO, ringing the bell from Starbase/AIAustin venture funding hits an all-time high, led by AI and robotics/NationalTesla extends its Austin robotaxi service across the full metro/NationalTrump signs AI executive order pushing federal control over state rules/StartupsSaronic launches its first Marauder unmanned vessel, built in under a year/PeopleBryan Chambers Takes the Helm at Capital Factory After Cofounder's Death/PeopleJoshua Baer, Architect of Austin's Startup Boom, Dies at 50/NationalSpaceX goes public in record $75B IPO, ringing the bell from Starbase/AIAustin venture funding hits an all-time high, led by AI and robotics/NationalTesla extends its Austin robotaxi service across the full metro/NationalTrump signs AI executive order pushing federal control over state rules/StartupsSaronic launches its first Marauder unmanned vessel, built in under a year/
Tagged

biotech

4 stories

StartupsMara Whitfield · Apr 30

Colossal Biosciences adds the bluebuck to its de-extinction roster

The Austin biotech named the extinct South African antelope as the sixth species in its de-extinction portfolio and its first project on mainland Africa.

Colossal Biosciences, Austin's de-extinction decacorn, keeps raising
AIDev Okonkwo · Apr 30

Colossal Biosciences, Austin's de-extinction decacorn, keeps raising

The genetic-engineering company is past a $10 billion valuation as it pushes mammoth, dire wolf and bluebuck programs forward.

PeopleSloane Reyes · Apr 9

Ben Lamm said his company brought back the dire wolf. The debate hasn't stopped since.

The serial entrepreneur turned a de-extinction moonshot into a multibillion-dollar biotech, and a lightning rod for scientific argument.

FundingMara Whitfield · Mar 19

Austin neuromodulation startup raises $25M Series A for non-invasive ultrasound therapy

The company is developing non-invasive ultrasound treatments aimed at immune-mediated diseases.

← Back to Next in Austin